ANGO (STOCKS)
AngioDynamics, Inc.
$10.240000
+0.440000 (+4.49%)
Prev close: $9.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James Christopher Clemmer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $423.31M
- Employees
- 675
- P/E (TTM)
- -13.48
- P/B (TTM)
- 2.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$0.02 | $-0.11 | +0.1322 | +117.83% |
|
Dec 2025 (Q2)
|
$0.00 | $-0.10 | +0.1020 | +100.00% |
|
Sep 2025 (Q1)
|
$-0.10 | $-0.12 | +0.0199 | +16.60% |
|
Jun 2025 (Q4)
|
$-0.03 | $-0.12 | +0.0924 | +75.49% |
Financial Statements
| Revenues | $313.73M |
| Benefits Costs and Expenses | $345.10M |
| Cost Of Revenue | $143.39M |
| Costs And Expenses | $345.10M |
| Gross Profit | $170.34M |
| Operating Expenses | $205.86M |
| Depreciation and Amortization | $23.19M |
| Research and Development | $27.86M |
| Other Operating Expenses | $154.81M |
| Operating Income/Loss | -$35.52M |
| Income/Loss From Continuing Operations After Tax | -$31.39M |
| Income/Loss From Continuing Operations Before Tax | -$31.38M |
| Income Tax Expense/Benefit | $12.00K |
| Income Tax Expense/Benefit, Deferred | -$200.00K |
| Net Income/Loss | -$31.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.75 |
| Diluted Earnings Per Share | -$0.75 |
| Basic Average Shares | 41,511,000 |
| Diluted Average Shares | 41,511,000 |
| Assets | $260.68M |
| Current Assets | $155.55M |
| Inventory | $58.58M |
| Other Current Assets | $96.97M |
| Noncurrent Assets | $105.13M |
| Fixed Assets | $29.14M |
| Intangible Assets | $65.49M |
| Other Non-current Assets | $10.50M |
| Liabilities | $87.32M |
| Current Liabilities | $66.07M |
| Accounts Payable | $29.11M |
| Wages | $19.07M |
| Other Current Liabilities | $17.89M |
| Noncurrent Liabilities | $21.26M |
| Equity | $173.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $173.36M |
| Liabilities And Equity | $260.68M |
| Net Cash Flow From Operating Activities | $4.45M |
| Net Cash Flow From Operating Activities, Continuing | $4.45M |
| Net Cash Flow From Investing Activities | -$7.30M |
| Net Cash Flow From Investing Activities, Continuing | -$7.30M |
| Net Cash Flow From Financing Activities | -$5.10M |
| Net Cash Flow From Financing Activities, Continuing | -$5.10M |
| Exchange Gains/Losses | $1.00M |
| Net Cash Flow | -$6.95M |
| Net Cash Flow, Continuing | -$7.95M |
| Comprehensive Income/Loss | -$25.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$25.15M |
| Other Comprehensive Income/Loss | $8.84M |